| 摘要 |
<p>The present invention relates to the use of antigens derived from the RD1 or RD2 regions of the Mycobacterium tuberculosis, Mycobacterium bovis or Mycobacterium africanum genomes, and peptides derived therefrom, as diagnostic reagents, in particular in the context of diagnostic kits. In addition, certain of these peptides, as well as other antigens and peptides derived from the RD14 region of the genome are suitable for use as vaccines. Novel fusion peptides are also part of the invention.</p> |
